These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38431747)

  • 41. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
    Keating GM
    BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
    Larson RA; Fretzin MH; Dodge RK; Schiffer CA
    Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia.
    Woo MH; Hak LJ; Storm MC; Evans WE; Sandlund JT; Rivera GK; Wang B; Pui CH; Relling MV
    Leukemia; 1998 Oct; 12(10):1527-33. PubMed ID: 9766495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase.
    Boissel N; Sender LS
    J Adolesc Young Adult Oncol; 2015 Sep; 4(3):118-28. PubMed ID: 26421220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
    Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
    CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study.
    Silva WFD; Massaut IHB; Bendlin RM; Rosa LI; Velloso EDRP; Rego EM; Rocha V
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e523-e528. PubMed ID: 32389674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
    Sulis ML; Blonquist TM; Stevenson KE; Hunt SK; Kay-Green S; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JG; Neuberg DS; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2018 May; 65(5):e26952. PubMed ID: 29319209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience.
    Ruiz-Delgado GJ; Macías-Gallardo J; Lutz-Presno JA; Montes-Montiel M; Ruiz-Argüelles GJ
    Leuk Lymphoma; 2011 Feb; 52(2):314-6. PubMed ID: 21054153
    [No Abstract]   [Full Text] [Related]  

  • 50. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic pseudocyst complicating treatment of acute lymphoblastic leukemia.
    Tomar S; Bakhshi S; Kabra SK; Arya LS
    Indian Pediatr; 2003 Jul; 40(7):670-2. PubMed ID: 12881625
    [No Abstract]   [Full Text] [Related]  

  • 52. The molecular perspective: l-asparaginase.
    Goodsell DS
    Stem Cells; 2005 May; 23(5):710-1. PubMed ID: 15849179
    [No Abstract]   [Full Text] [Related]  

  • 53. Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
    Samarasinghe S; Dhir S; Slack J; Iyer P; Wade R; Clack R; Vora A; Goulden N
    Br J Haematol; 2013 Sep; 162(5):710-3. PubMed ID: 23750892
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors.
    Al-Nawakil C; Willems L; Mauprivez C; Laffy B; Benm'rad M; Tamburini J; Fontaine H; Sogni P; Terris B; Bouscary D; Moachon L
    Leuk Lymphoma; 2014 Jul; 55(7):1670-4. PubMed ID: 24090500
    [No Abstract]   [Full Text] [Related]  

  • 55. Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase.
    Strickler N; Balabanov S; Casauro K; Schanz U; Manz MG; Gerber B
    Leuk Lymphoma; 2018 Apr; 59(4):855-862. PubMed ID: 28728499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 57. Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes.
    Cassaday RD
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101519. PubMed ID: 38092476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 59. L-asparaginase induced acute parotitis during intensification therapy of acute lymphoblastic leukemia.
    Kathwate J; Mundada S; Patil P
    Indian J Cancer; 2014; 51(4):537. PubMed ID: 26842187
    [No Abstract]   [Full Text] [Related]  

  • 60. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.